Skip to main content

Table 1 Serological analysis of CMV, EBV and HHV-8 antibodies over time

From: Fulminant anaplastic large cell lymphoma (ALCL) concomitant with primary cytomegalovirus (CMV) infection, and human herpes virus 8 (HHV-8) infection together with Epstein-Barr-virus (EBV) reactivation in a patient with asymptomatic HIV-infection

Test used

9 months prior to admission

Day 3

Day 10

Day 21

CMV IgG EIA

<100a

< 100a

500b

1000b

CMV-IgM capture EIA

<100a

< 100a

100b

Close to cut-offa

EBV-EIA (EBNA) IgG

> = 20b

> = 20b

 

> = 20b

EBV-IgG VCA EIA, U/mL

75b

120b

 

130b

EBV-IgM EIA

Negative

Negative

 

<= 40a

HHV-8 IFT (lytic antigens)

Negative

Positive

 

Positive

HHV-8 LANA (latent nuclear antigens)

Negative

Negative

 

Negative

  1. EIA enzyme immunosorbent assay, VCA viral capsid antigen
  2. anegative
  3. bpositive